Genocea Biosciences, Inc. (GNCA) financial statements (2022 and earlier)

Company profile

Business Address 100 ACORN PARK DRIVE
CAMBRIDGE, MA 02140
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments37,14879,76940,12726,36112,27363,36294,328
Cash and cash equivalents37,14879,76940,12726,36112,27327,42417,259
Short-term investments     35,93877,069
Deferred costs   110571339304
Other undisclosed current assets4,6742,4581,457586237587561
Total current assets:41,82282,22741,58427,05713,08164,28895,193
Noncurrent Assets
Finance lease, right-of-use asset 30150
Operating lease, right-of-use asset7,4209,2786,156
Property, plant and equipment5,8415,1232,6172,5823,4604,8714,083
Long-term investments and receivables      12,104
Long-term investments      12,104
Restricted cash and investments631631631316316316316
Other noncurrent assets2531,2041,4731,160631421446
Total noncurrent assets:14,14516,26611,0274,0584,4075,60816,949
TOTAL ASSETS:55,96798,49352,61131,11517,48869,896112,142
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,5223,3132,7983,8065,3465,1333,493
Accounts payable5005345531,6593,5163,0431,757
Employee-related liabilities3,0222,7792,2452,1471,8302,0901,736
Deferred revenue1,7001,641 
Debt4,64113,8841,1175,2576,6593,149 
Restructuring reserve    44  
Deferred revenue and credits  235
Other undisclosed current liabilities8,8206,1572,3661,6693,7302,0882,239
Total current liabilities:18,68324,9956,28110,73215,77910,3705,967
Noncurrent Liabilities
Long-term debt and lease obligation4,1468,39818,8029,5657,65213,80916,477
Long-term debt, excluding current maturities4,146 13,4079,5657,65213,80916,477
Finance lease, liability  22
Operating lease, liability 8,3985,373
Liabilities, other than long-term debt   1110717637
Other liabilities   1110717637
Other undisclosed noncurrent liabilities6,06347,7202,4863,472   
Total noncurrent liabilities:10,20964,51621,28813,0487,75913,98516,514
Total liabilities:28,89289,51127,56923,78023,53824,35522,481
Stockholders' equity
Stockholders' equity attributable to parent, including:27,0758,98225,0427,335(6,050)45,54189,661
Common stock58532787292828
Additional paid in capital434,881383,597355,268298,551258,114252,996247,550
Accumulated other comprehensive loss      (7)
Accumulated deficit(407,864)(374,668)(330,954)(292,004)(264,193)(207,483)(157,910)
Other undisclosed stockholders' equity attributable to parent  701701   
Total stockholders' equity:27,0758,98225,0427,335(6,050)45,54189,661
TOTAL LIABILITIES AND EQUITY:55,96798,49352,61131,11517,48869,896112,142

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues1,6411,359   235670
Revenue, net 235670
Sublease income1,400  
Gross profit:1,6411,359   235670
Operating expenses(53,734)(48,348)(38,989)(39,518)(55,255)(48,480)(42,036)
Operating loss:(52,093)(46,989)(38,989)(39,518)(55,255)(48,245)(41,366)
Nonoperating income (expense)18,8973,2753911,707(1,455)(1,328)(1,117)
Investment income, nonoperating    250410157
Other nonoperating expense(122)(4,234)(1)(2,029)   
Interest and debt expense(1,121)(1,380)(946)(1,021)(1,705)(1,738) 
Net loss:(34,317)(45,094)(39,896)(28,832)(58,415)(51,311)(42,483)
Other undisclosed net income attributable to parent1,1211,3809461,0211,7051,738 
Net loss attributable to parent:(33,196)(43,714)(38,950)(27,811)(56,710)(49,573)(42,483)
Preferred stock dividends and other adjustments 8,067     
Other undisclosed net loss available to common stockholders, basic (16,134)     
Net loss available to common stockholders, diluted:(33,196)(51,781)(38,950)(27,811)(56,710)(49,573)(42,483)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(34,317)(45,094)(39,896)(28,832)(58,415)(51,311)(42,483)
Comprehensive loss:(34,317)(45,094)(39,896)(28,832)(58,415)(51,311)(42,483)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1,1211,3809461,0211,7051,738(7)
Comprehensive loss, net of tax, attributable to parent:(33,196)(43,714)(38,950)(27,811)(56,710)(49,573)(42,490)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: